Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients.

Hammer J, Geinitz H, Nieder C, Track C, Thames HD, Seewald DH, Petzer AL, Helfgott R, Spiegl KJ, Heck D, Bräutigam E.

Clin Breast Cancer. 2019 Feb;19(1):58-62. doi: 10.1016/j.clbc.2018.08.001. Epub 2018 Aug 22.

PMID:
30197244
2.

Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles.

Khoo AM, Cho SH, Reynoso FJ, Aliru M, Aziz K, Bodd M, Yang X, Ahmed MF, Yasar S, Manohar N, Cho J, Tailor R, Thames HD, Krishnan S.

Sci Rep. 2017 Dec 22;7(1):18044. doi: 10.1038/s41598-017-18304-y.

3.

Lower mean heart dose with deep inspiration breath hold-whole breast irradiation compared with brachytherapy-based accelerated partial breast irradiation for women with left-sided tumors.

Holliday EB, Kirsner SM, Thames HD, Mason BE, Nelson CL, Bloom ES.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):80-85. doi: 10.1016/j.prro.2016.07.007. Epub 2016 Jul 28.

PMID:
28274398
4.

Rod Withers' Data are Available Online.

Thames HD, Hunter NR, Mason KA.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):435-436. doi: 10.1016/j.ijrobp.2016.10.014. No abstract available.

PMID:
28068249
5.

The Withers archive: Online availability of rod Wither's data.

Thames HD, Hunter NR, Mason KA.

Radiother Oncol. 2016 Dec;121(3):475-477. doi: 10.1016/j.radonc.2016.10.004. Epub 2016 Oct 28.

PMID:
28029406
6.

The Withers Archive: Online Availability of H. Rodney Withers' Data.

Thames HD, Hunter NR, Mason KA.

Radiat Res. 2016 Dec;186(6):659-661. doi: 10.1667/RR4638.1. Epub 2016 Dec 7. No abstract available.

PMID:
27925862
7.

The Limitations of Model-Based Experimental Design and Parameter Estimation in Sloppy Systems.

White A, Tolman M, Thames HD, Withers HR, Mason KA, Transtrum MK.

PLoS Comput Biol. 2016 Dec 6;12(12):e1005227. doi: 10.1371/journal.pcbi.1005227. eCollection 2016 Dec.

8.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG.

Radiother Oncol. 2016 Dec;121(3):364-373. doi: 10.1016/j.radonc.2016.11.008. Epub 2016 Nov 29.

PMID:
27913065
9.

Articular cartilage scores in cranial cruciate ligament-deficient dogs with or without bucket handle tears of the medial meniscus.

Kaufman K, Beale BS, Thames HD, Saunders WB.

Vet Surg. 2017 Jan;46(1):120-129. doi: 10.1111/vsu.12584. Epub 2016 Nov 28.

PMID:
27893158
10.

The Withers Archive: online availability of H. Rodney Withers' data.

Thames HD, Hunter NR, Mason KA.

Int J Radiat Biol. 2016 Dec;92(12):855-857. Epub 2016 Nov 8.

PMID:
27807995
11.

Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response.

Smith DL, Debeb BG, Thames HD, Woodward WA.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):179-87. doi: 10.1016/j.ijrobp.2016.04.014. Epub 2016 Apr 19.

12.

TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.

Wang L, Zhang P, Molkentine DP, Chen C, Molkentine JM, Piao H, Raju U, Zhang J, Valdecanas DR, Tailor RC, Thames HD, Buchholz TA, Chen J, Ma L, Mason KA, Ang KK, Meyn RE, Skinner HD.

Oncogene. 2017 Feb 9;36(6):820-828. doi: 10.1038/onc.2016.250. Epub 2016 Jul 18.

13.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.

Linge A, Löck S, Gudziol V, Nowak A, Lohaus F, von Neubeck C, Jütz M, Abdollahi A, Debus J, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Bayer C, Belka C, Pigorsch S, Combs SE, Welz S, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Baumann M, Krause M; DKTK-ROG.

Clin Cancer Res. 2016 Jun 1;22(11):2639-49. doi: 10.1158/1078-0432.CCR-15-1990. Epub 2016 Jan 11.

14.

Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.

Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, Kaseb AO, Bishop AJ, Swanick CW, Koay EJ, Thames HD, Hong TS, Das P, Crane CH.

J Clin Oncol. 2016 Jan 20;34(3):219-26. doi: 10.1200/JCO.2015.61.3778. Epub 2015 Oct 26. Erratum in: J Clin Oncol. 2019 Apr 10;37(11):942.

15.

Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses.

Rosenthal DI, Fuller CD, Peters LJ, Thames HD Jr.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):715-7. doi: 10.1016/j.ijrobp.2015.02.051. No abstract available.

16.

The origins of translational radiation oncology - In memoriam H. Rodney Withers (21 September 1932-25 February 2015).

Thames HD, Peters LJ, McBride WH, Mason KA.

Radiother Oncol. 2015 Apr;115(1):1-2. doi: 10.1016/j.radonc.2015.04.014. No abstract available.

PMID:
26055464
17.

In memoriam: H. Rodney Withers (21 September 1932-25 February 2015).

McBride WH, Mason KA, Peters LJ, Thames HD.

Radiat Res. 2015 May;183(5):586-8. No abstract available.

PMID:
26000760
18.

Dr. H. Rodney Withers (1932 - 2015).

McBride WH, Mason KA, Peters LJ, Thames HD.

Int J Radiat Biol. 2015 May;91(5):459-61. doi: 10.3109/09553002.2015.1040202. No abstract available.

PMID:
25908167
19.

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, von Neubeck C, Baretton GB, Löck S, Thames HD, Krause M, Baumann M; DKTK-ROG.

Radiother Oncol. 2014 Dec;113(3):317-23. doi: 10.1016/j.radonc.2014.11.011. Epub 2014 Dec 2.

20.

A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer.

Lin SH, Zhang J, Giri U, Stephan C, Sobieski M, Zhong L, Mason KA, Molkentine J, Thames HD, Yoo SS, Heymach JV.

J Thorac Oncol. 2014 Jul;9(7):965-73. doi: 10.1097/JTO.0000000000000199.

21.

Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses.

Sheu T, Molkentine J, Transtrum MK, Buchholz TA, Withers HR, Thames HD, Mason KA.

Radiother Oncol. 2013 Oct;109(1):21-5. doi: 10.1016/j.radonc.2013.08.027. Epub 2013 Sep 20.

PMID:
24060173
22.

Residual γH2AX foci predict local tumour control after radiotherapy.

Koch U, Höhne K, von Neubeck C, Thames HD, Yaromina A, Dahm-Daphi J, Baumann M, Krause M.

Radiother Oncol. 2013 Sep;108(3):434-9. doi: 10.1016/j.radonc.2013.06.022. Epub 2013 Jul 25.

PMID:
23891089
23.

GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial.

Soliman M, Yaromina A, Appold S, Zips D, Reiffenstuhl C, Schreiber A, Thames HD, Krause M, Baumann M.

Radiother Oncol. 2013 Mar;106(3):299-304. doi: 10.1016/j.radonc.2012.12.008. Epub 2013 Jan 17.

PMID:
23333018
24.

Prognostic value of HIF-1α expression during fractionated irradiation.

Helbig L, Yaromina A, Sriramareddy SN, Böke S, Koi L, Thames HD, Baumann M, Zips D.

Strahlenther Onkol. 2012 Nov;188(11):1031-7. doi: 10.1007/s00066-012-0150-z. Epub 2012 Sep 29.

PMID:
23053140
25.

Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.

Hunter NR, Valdecanas D, Liao Z, Milas L, Thames HD, Mason KA.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):472-6. doi: 10.1016/j.ijrobp.2012.04.025. Epub 2012 Jun 5.

PMID:
22672748
26.

Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.

Menegakis A, Eicheler W, Yaromina A, Thames HD, Krause M, Baumann M.

Radiother Oncol. 2011 Jul;100(1):137-44. doi: 10.1016/j.radonc.2011.07.001. Epub 2011 Aug 5.

PMID:
21821302
27.

Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control.

Zips D, Böke S, Kroeber T, Meinzer A, Brüchner K, Thames HD, Baumann M, Yaromina A.

Strahlenther Onkol. 2011 May;187(5):306-10. doi: 10.1007/s00066-011-2210-1. Epub 2011 Apr 26.

PMID:
21533758
28.

Estimation of α/β for late rectal toxicity based on RTOG 94-06.

Tucker SL, Thames HD, Michalski JM, Bosch WR, Mohan R, Winter K, Cox JD, Purdy JA, Dong L.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):600-5. doi: 10.1016/j.ijrobp.2010.11.080. Epub 2011 Mar 4.

29.

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1253-60. doi: 10.1016/j.ijrobp.2010.01.069. Epub 2010 Jul 2.

30.

Ultraviolet A does not induce melanomas in a Xiphophorus hybrid fish model.

Mitchell DL, Fernandez AA, Nairn RS, Garcia R, Paniker L, Trono D, Thames HD, Gimenez-Conti I.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9329-34. doi: 10.1073/pnas.1000324107. Epub 2010 May 3.

31.

The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.

Thames HD, Kuban D, Levy LB, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.

Radiother Oncol. 2010 Jul;96(1):6-12. doi: 10.1016/j.radonc.2010.03.020. Epub 2010 Apr 17.

PMID:
20400191
32.

Detoxication of sulfur half-mustards by nucleophilic scavengers: robust activity of thiopurines.

Liu J, Powell KL, Thames HD, MacLeod MC.

Chem Res Toxicol. 2010 Mar 15;23(3):488-96. doi: 10.1021/tx900190j.

33.

Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining.

Menegakis A, Yaromina A, Eicheler W, Dörfler A, Beuthien-Baumann B, Thames HD, Baumann M, Krause M.

Int J Radiat Biol. 2009 Nov;85(11):1032-41. doi: 10.3109/09553000903242149.

PMID:
19895280
34.

Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter?

Torres MA, Jhingran A, Thames HD Jr, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ.

Int J Gynecol Cancer. 2009 Aug;19(6):1107-12. doi: 10.1111/IGC.0b013e3181a83d3e.

PMID:
19820377
35.

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.

Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):775-81. doi: 10.1016/j.ijrobp.2009.02.032. Epub 2009 Jun 8.

PMID:
19515503
36.

The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.

Wang A, Arantes S, Yan L, Kiguchi K, McArthur MJ, Sahin A, Thames HD, Aldaz CM, Macleod MC.

BMC Cancer. 2008 Sep 22;8:268. doi: 10.1186/1471-2407-8-268.

37.

Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.

Torres MA, Jhingran A, Thames HD Jr, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):118-25. Epub 2007 Sep 14.

PMID:
17869451
39.

High-affinity triplex-forming oligonucleotide target sequences in mammalian genomes.

Wu Q, Gaddis SS, MacLeod MC, Walborg EF, Thames HD, DiGiovanni J, Vasquez KM.

Mol Carcinog. 2007 Jan;46(1):15-23.

PMID:
17013831
40.

Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.

Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh JA, Quennet V, Walenta S, Mueller-Klieser W, Baumann M.

Radiother Oncol. 2006 Nov;81(2):122-9. Epub 2006 Sep 7.

PMID:
16956683
41.

Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis.

Horwitz EM, Levy LB, Thames HD, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA.

Cancer. 2006 Oct 1;107(7):1496-502.

42.

Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.

Krause M, Zips D, Thames HD, Kummermehr J, Baumann M.

Radiother Oncol. 2006 Aug;80(2):112-22. Epub 2006 Aug 17. Review.

PMID:
16916560
43.

A web-based search engine for triplex-forming oligonucleotide target sequences.

Gaddis SS, Wu Q, Thames HD, DiGiovanni J, Walborg EF, MacLeod MC, Vasquez KM.

Oligonucleotides. 2006 Summer;16(2):196-201.

PMID:
16764543
44.

Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.

Thames HD, Kuban DA, DeSilvio ML, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):975-81. Epub 2006 Jun 5.

PMID:
16750319
45.

The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?

Oh JL, Bonnen M, Outlaw ED, Schechter NR, Perkins GH, Strom EA, Babiera G, Oswald MJ, Allen PK, Thames HD, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1345-52. Epub 2006 Jun 5.

PMID:
16750315
46.

Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study.

Tucker SL, Zhang M, Dong L, Mohan R, Kuban D, Thames HD.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1255-64.

PMID:
16504763
47.

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.

Ray ME, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1140-50. Epub 2005 Sep 29.

PMID:
16198506
48.

Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?

Yaromina A, Hölscher T, Eicheler W, Rosner A, Krause M, Hessel F, Petersen C, Thames HD, Baumann M, Zips D.

Radiother Oncol. 2005 Aug;76(2):206-12.

PMID:
16024121
49.

Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.

Krause M, Ostermann G, Petersen C, Yaromina A, Hessel F, Harstrick A, van der Kogel AJ, Thames HD, Baumann M.

Radiother Oncol. 2005 Aug;76(2):162-7.

PMID:
16024114
50.

Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.

Zips D, Eicheler W, Geyer P, Hessel F, Dörfler A, Thames HD, Haberey M, Baumann M.

Cancer Res. 2005 Jun 15;65(12):5374-9.

Supplemental Content

Loading ...
Support Center